The DOI matches its Crossref record.
Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers
Abstract
The effect of zimelidine, a specific serotonin-reuptake inhibitor, on alcohol intake was tested in 13 healthy male, nondepressed heavy drinkers who were randomly allocated to receive zimelidine or placebo in a double-blind, crossover experiment. There were five 2-wk experimental periods (baseline, placebo 1 and 2, and zimelidine 1 and 2). Treatment was discontinued in three subjects due to a suspected adverse reaction and three other subjects dropped out. Thus, 13 subjects participated in at least two experimental drug periods and only 10 participated in all the periods. In the 13 subjects zimelidine increased the days of abstinence and decreased the daily number of drinks consumed, whereas in the 10 subjects only the number of days of abstinence increased. Subjects did not report aversive alcohol-sensitizing reactions. Spielberger state-anxiety test scores and depression scores (Montgomery/Asberg and Hamilton) were low at the beginning and throughout the study. Our data suggest that zimelidine modifies alcohol intake by a different mechanism than previously tested drugs, possibly by modulating the central neural mechanism that controls drinking of alcohol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A motivational model of alcohol use.
Cox, W. M., & Klinger, E. (1988) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.97.2.168 · Cited by 1,475
Reconciling the role of central serotonin neurons in human and animal behavior
Soubrié, P. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00022871 · Cited by 996
Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro
Brodie, M. S., Shefner, S. A., & Dunwiddie, T. V. (1990) · Brain Research · doi:10.1016/0006-8993(90)91118-z · Cited by 488
Weiss, F., Parsons, L. H., Schulteis, G., Hyytiä, P., Lorang, M. T., Bloom, F. E., & Koob, G. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03474.1996 · Cited by 457
Serotonin and alcohol intake, abuse, and dependence: Clinical evidence
LeMarquand, D., Pihl, R. O., & Benkelfat, C. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90630-0 · Cited by 335
Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.391 · Cited by 289
Murphy, J. M., McBride, W. J., Lumeng, L., & Li, T.-K. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90134-1 · Cited by 280
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Mason, B. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530340025025 · Cited by 257
Fluoxetine reduces intravenous cocaine self-administration in rats
Carroll, M. E., Lac, S. T., Asencio, M., & Kragh, R. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90232-7 · Cited by 254
Buspirone Treatment of Anxious Alcoholics: A Placebo-Controlled Trial
Kranzler, H. R. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950090052008 · Cited by 248
Behavioral Assessment of Gambling: An Application of the Timeline Followback Method.
Weinstock, J., Whelan, J. P., & Meyers, A. W. (2004) · Psychological Assessment · doi:10.1037/1040-3590.16.1.72 · Cited by 160
Metadata
- Authors
- Naranjo, C. A., Sellers, E. M., Roach, C. A., Woodley, D. V., Sanchez-Craig, M., & Sykora, K.
- Venue
- Clinical Pharmacology and Therapeutics
- Publisher
- Wiley
- Published
- 1984-03
- Volume
- 35
- Issue
- 3
- Pages
- 374-381
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W1992796495
- Cited by
- 222
- References
- 0
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.